One-Third of Clinical Trial Results Never Disclosed, Study Finds
▻http://www.bloomberg.com/news/articles/2016-02-17/one-third-of-clinical-trial-results-never-disclosed-study-finds
Avec une explication à couper le souffle,
Ellison said researchers may not publish their results if the data isn’t positive or interesting, noting that it’s harder for studies with negative results to be accepted by medical journals. He said that regardless of the outcome of tests, it was still important to publish.
“Pharmaceutical companies, the government and foundations invest a lot of money in clinical trials,” he said. “If the results aren’t made public, that’s wasted money.”
Alors que la principale motivation est de ne pas décourager les prescriptions sans preuve d’efficacité, sinon dangereuses.